Results 15,561-15,580 of 46,036 for speaker:Simon Harris

Written Answers — Department of Health: Hospital Appointments Status (7 Nov 2017)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The scheduling...

Written Answers — Department of Health: HSE Reports (7 Nov 2017)

Simon Harris: I have asked the HSE to respond to the Deputy directly on this matter.

Written Answers — Department of Health: Primary Care Centres (7 Nov 2017)

Simon Harris: I propose to take Questions Nos. 650 and 651 together. As these questions relate to service matters, I have arranged for them to be referred to the Health Service Executive (HSE) for direct reply.

Written Answers — Department of Health: Hospital Appointments Status (7 Nov 2017)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The scheduling...

Written Answers — Department of Health: Hospital Services (7 Nov 2017)

Simon Harris: As this is a service issue, I have asked the HSE to respond to you directly.

Written Answers — Department of Health: Assisted Human Reproduction (7 Nov 2017)

Simon Harris: On Tuesday 3 October 2017 the Government approved the drafting of a Bill on assisted human reproduction (AHR) and associated areas of research. Officials in my Department are engaging with the Office of the Attorney General in relation to the process of drafting this Bill. The General Scheme is published on the Department's website and has been submitted to the Joint Oireachtas Committee on...

Written Answers — Department of Health: Vaccination Programme (7 Nov 2017)

Simon Harris: Flu vaccine is the best protection against the flu. The Centre for Disease Control and Prevention (CDC) in the USA states that the influenza vaccine is 50-60% effective in preventing hospitalisation among elderly persons and 80% effective in preventing death among elderly persons. It is too early to tell how effective this season’s flu vaccine will be, as there is very little...

Written Answers — Department of Health: Hospital Services (7 Nov 2017)

Simon Harris: I have no plans to move South Tipperary General Hospital out of the South South West Hospital Group. As the Deputy may be aware, the report of the cross-party Committee on the Future of Healthcare was published on 30 May last. It made a number of recommendations in relation to Hospital Groups, including consideration of the current alignment of hospital groups and CHOs. I have advised...

Written Answers — Department of Health: Health Services Provision (7 Nov 2017)

Simon Harris: Patients can seek to access health care in an other EU/EEA member state via two different schemes. Where a service is provided in Ireland but a patient wishes to access care in another EU/EEA Member State, this can be possible by seeking treatment under the Directive on Patients' Rights in Cross Border Healthcare, otherwise known as the Cross Border Directive (CBD). The CBD provides...

Written Answers — Department of Health: National Children's Hospital Expenditure (7 Nov 2017)

Simon Harris: I propose to take Questions Nos. 662 and 669 together. Everyone involved with this project holds the view that safety is paramount in relation to this project and ensuring that children, parents and staff operate within a safe environment. The National Paediatric Hospital Development Board (NPHDB) has statutory responsibility for the construction of the new children’s hospital and...

Written Answers — Department of Health: Departmental Websites (7 Nov 2017)

Simon Harris: I propose to take Questions Nos. 664, 691 and 692 together. My Department's website was last redeveloped in 2013/2014. As part of the Government's eGovernment strategy 2017- 2020 the Office of the Chief Information Officer has been working on the development of a Digital Service Gateway - a single digital point where citizens can easily access information about the Government services that...

Written Answers — Department of Health: Disease Management (7 Nov 2017)

Simon Harris: The Irish Society for Colitis and Crohn’s disease met with the Department of Health and HSE officials earlier this year. During this meeting the HSE outlined the services they provide to tackle the disease. The requirements to improve access to specialised nurses and the means of providing information to support self -management was also discussed. A meeting between the Minister and...

Written Answers — Department of Health: Assisted Human Reproduction (7 Nov 2017)

Simon Harris: As the Deputy will be aware, on Tuesday 3 October 2017 the Government approved the drafting of a Bill on assisted human reproduction (AHR) and associated areas of research. Officials in my Department are engaging with the Office of the Attorney General in relation to the process of drafting this Bill. The General Scheme is published on the Department's website and has been submitted to the...

Written Answers — Department of Health: Hospital Appointments Status (7 Nov 2017)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The scheduling...

Written Answers — Department of Health: Health Services Provision (7 Nov 2017)

Simon Harris: As the Deputy is aware there are a number of serious care and patient safety issues raised across a number of services in relation to this case. Because of the complexity and range of matters raised, the HSE's Quality Assurance and Verification Division has been asked by the Director of the National Patient Safety Office in my Department to follow up regarding actions required and...

Written Answers — Department of Health: Rare Diseases Strategy Implementation (7 Nov 2017)

Simon Harris: A National Rare Disease Plan for Ireland was launched by the Minister in July 2014. This is a generic policy framework for rare diseases. The scope of the plan is broad given that there are 8,000 rare diseases approximately affecting millions of EU citizens; and consequently, there can be a dearth of expertise and knowledge about some rare diseases, simply because they are so rare. Earlier...

Written Answers — Department of Health: Long-Term Illness Scheme (7 Nov 2017)

Simon Harris: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Drugs Payment Scheme Coverage (7 Nov 2017)

Simon Harris: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Health Services (7 Nov 2017)

Simon Harris: I propose to take Questions Nos. 676 and 838 together. As you know I wrote to you on this matter yesterday. My Department has been working on a proposal for a national review of cardiology services which is now at an advanced stage and which I plan to commence shortly.

Written Answers — Department of Health: Rare Diseases (7 Nov 2017)

Simon Harris: The National Centre for Pharmacoeconomics (NCPE) conducts the economic evaluation of new and existing technologies (e.g. pharmaceuticals, vaccines, diagnostics) to determine their cost effectiveness or value for money. A new Committee called the “Rare Diseases Medicinal Products/Technology Review Committee” was established in June 2017 by the NCPE. The terms of reference for...